Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000015/S057

Cochlear Auditory Brainstem Implant System

Cochlear Americas · Decision date Sep 28, 2026

MEDTECHLEDGER EXPLANATIONP000015/S057

What did the FDA decide?

The FDA recorded decision OK30 on 2026-09-28 for P000015/S057, a PMA supplement to the Cochlear Auditory Brainstem Implant System held by Cochlear Americas. The supplement is a 30-Day Notice filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device category is Implant, auditory brainstem, with product code MHE, in the Ear, Nose, Throat specialty.

The recorded statement covers a change to the joining process in the manufacturing of the NEUF Child Lock component in Cochlear Sound Processors. That scope concerns a component and its manufacturing process, not a new approval of the full implant system. The public documentation includes no documents, so the notice text, any FDA review detail and the basis for OK30 are not available here; the clinical effect of the joining-process change is likewise unstated.

FDA approval order statement

a change to the joining process in the manufacturing of the NEUF Child Lock component in Cochlear Sound Processors
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Sep 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000015/S057
Regulatory pathway
PMA supplement
Product code
MHE
Decision code
OK30
Decision date
Sep 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, auditory brainstem.

Product code
MHE
FDA device class
3

For the original device and its historical approval scope, see PMA P000015. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000015 · Original PMA

    NUCLEUS 24 AUDITORY BRAINSTEM IMPLANT SYSTEM

  2. P000015/S057 received

    Application receipt date recorded by FDA.

  3. P000015/S057 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P000015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000015

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA approvalOct 20, 2000FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cochlear Americas

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10350 Park Meadows Dr., Lone Tree, CO, 80124

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records